Promoting AAV vectors to safety

Why promoters, other genetic cargo in AAV vectors should be tested for toxicity

Companies looking to make AAVs safer for gene therapies may need to test the vectors' genomic cargo for toxicity, according to a new study from a Harvard and Hong Kong group.

Adeno-associated viral (AAV) vectors are widely used for gene therapies

Read the full 406 word article

User Sign In